CID 3077091

Brn 4263735

Structural Information

Molecular Formula
C13H13N3O3
SMILES
CC(=O)NC1=CC2=C(C=C1)OCC3C2=NNC(=O)C3
InChI
InChI=1S/C13H13N3O3/c1-7(17)14-9-2-3-11-10(5-9)13-8(6-19-11)4-12(18)15-16-13/h2-3,5,8H,4,6H2,1H3,(H,14,17)(H,15,18)
InChIKey
ZFAWGPAAZREJSW-UHFFFAOYSA-N
Compound name
N-(3-oxo-2,4,4a,5-tetrahydrochromeno[4,3-c]pyridazin-9-yl)acetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

259.0957 Da
Monoisotopic Mass

-0.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 260.102976 156.4
[M+Na]+ 282.084918 163.5
[M-H]- 258.088424 158.0
[M+NH4]+ 277.129523 170.1
[M+K]+ 298.058858 160.4
[M+H-H2O]+ 242.092960 148.0
[M+HCOO]- 304.093901 170.8
[M+CH3COO]- 318.109551 166.7
[M+Na-2H]- 280.070366 163.3
[M]+ 259.09515142 153.5
[M]- 259.09624858 153.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.